Harrow Health, Inc.
USD41.15
-0.92 (-2.19%)
CEO
Mark L. Baum
IPO Date
2007-09-28
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$42.70
Prev. Close
$42.07
Day Low
$40.80
Day High
$42.73
52W Low
$28.54
52W High
$54.85
Market Cap
$1.53B
Volume
0.47M
| 5,248 |
| $0.00 |
| 22 Jun 2026 | Graves Adrienne L | director | A-Award | Acquired | 5,248 | $0.00 |
| 19 May 2026 | Graves Adrienne L | director | P-Purchase | Acquired | 1,000 | $31.07 |
| 19 May 2026 | SILVERNAIL LAUREN P | director | P-Purchase | Acquired | 1,000 | $31.00 |
| 18 May 2026 | Shojaei Amir | CHIEF SCIENTIFIC OFFICER | A-Award | Acquired | 10,000 | $0.00 |
| 15 May 2026 | BAUM MARK L | director, officer: CHIEF EXECUTIVE OFFICER | P-Purchase | Acquired | 10,000 | $30.20 |
| 15 May 2026 | BOLL ANDREW R. | PRESIDENT AND CFO | P-Purchase | Acquired | 3,500 | $29.90 |
| 5 Mar 2026 | Opaleye Management Inc. | 10 percent owner | S-Sale | Disposed | 59,000 | $39.15 |
| 5 Mar 2026 | Opaleye Management Inc. | 10 percent owner | S-Sale | Disposed | 1,309 | $39.15 |